AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY
Authors: BLANEY SM NEEDLE MN GILLESPIE A SATO JK REAMAN GH BERG SL ADAMSON PC KRAILO MD BLEYER WA POPLACK DG BALIS FM
Citation: Sm. Blaney et al., PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY, Clinical cancer research, 4(2), 1998, pp. 357-360
PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY
Authors: BLANEY SM NEEDLE MN GILLESPIE A SATO JK REAMAN GH BERG SL ADAMSON PC KRAILO MD BLEYER WA POPLACK DG BALIS FM
Citation: Sm. Blaney et al., PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY, Clinical cancer research, 4(2), 1998, pp. 357-360
PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF PYRAZOLOACRIDINE IN CHILDREN AND YOUNG-ADULTS WITH REFRACTORY CANCERS
Authors: BERG SL BLANEY SM ADAMSON PC OBRIEN M POPLACK DG ARNDT C BLATT J BALIS FM
Citation: Sl. Berg et al., PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF PYRAZOLOACRIDINE IN CHILDREN AND YOUNG-ADULTS WITH REFRACTORY CANCERS, Journal of clinical oncology, 16(1), 1998, pp. 181-186
NEW CYTOTOXIC DRUGS FOR INTRATHECAL ADMINISTRATION
Authors: BLANEY SM POPLACK DG
Citation: Sm. Blaney et Dg. Poplack, NEW CYTOTOXIC DRUGS FOR INTRATHECAL ADMINISTRATION, Journal of neuro-oncology, 38(2-3), 1998, pp. 219-223
DETECTION OF DOUBLE MINUTE CHROMOSOMES IN A CHILD WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: MURRAY JC POPLACK DG MAHONEY DH GRESIK MV HARRISON WR COOLEY LD
Citation: Jc. Murray et al., DETECTION OF DOUBLE MINUTE CHROMOSOMES IN A CHILD WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Cancer genetics and cytogenetics, 101(2), 1998, pp. 138-142
PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL METHOTREXATE AND MERCAPTOPURINE IN CHILDREN WITH LOWER RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - A JOINT CHILDRENS CANCER GROUP AND PEDIATRIC ONCOLOGY BRANCH STUDY
Authors: BALIS FM HOLCENBERG JS POPLACK DG GE J SATHER HN MURPHY RF AMES MM WASKERWITZ MJ TUBERGEN DG ZIMM S GILCHRIST GS BLEYER WA
Citation: Fm. Balis et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL METHOTREXATE AND MERCAPTOPURINE IN CHILDREN WITH LOWER RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - A JOINT CHILDRENS CANCER GROUP AND PEDIATRIC ONCOLOGY BRANCH STUDY, Blood, 92(10), 1998, pp. 3569-3577
A PEDIATRIC PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF THIOGUANINE ADMINISTERED BY CONTINUOUS IV INFUSION
Authors: KITCHEN BJ BALIS FM POPLACK DG OBRIEN M CRAIG CE ADAMSON PC
Citation: Bj. Kitchen et al., A PEDIATRIC PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF THIOGUANINE ADMINISTERED BY CONTINUOUS IV INFUSION, Clinical cancer research, 3(5), 1997, pp. 713-717
PHARMACOKINETIC VARIABILITY AND APPARENT DRUG-RESISTANCE
Authors: ADAMSON PC POPLACK DG
Citation: Pc. Adamson et Dg. Poplack, PHARMACOKINETIC VARIABILITY AND APPARENT DRUG-RESISTANCE, International journal of pediatric hematology/oncology, 4(6), 1997, pp. 525-530
PHASE-I TRIAL OF DOCETAXEL ADMINISTERED AS A 1-HOUR INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE AND CHILDRENS CANCER GROUP TRIAL
Authors: BLANEY SM SEIBEL NL OBRIEN M REAMAN GH BERG SL ADAMSON PC POPLACK DG KRAILO MD MOSHER R BALIS FM
Citation: Sm. Blaney et al., PHASE-I TRIAL OF DOCETAXEL ADMINISTERED AS A 1-HOUR INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE AND CHILDRENS CANCER GROUP TRIAL, Journal of clinical oncology, 15(4), 1997, pp. 1538-1543
RANDOMIZED TRIAL OF THE CARDIOPROTECTIVE AGENT ICRF-187 IN PEDIATRIC SARCOMA PATIENTS TREATED WITH DOXORUBICIN
Authors: WEXLER LH ANDRICH MP VENZON D BERG SL WEAVERMCCLURE L CHEN CC DILSIZIAN V AVILA N JAROSINSKI P BALIS FM POPLACK DG HOROWITZ ME
Citation: Lh. Wexler et al., RANDOMIZED TRIAL OF THE CARDIOPROTECTIVE AGENT ICRF-187 IN PEDIATRIC SARCOMA PATIENTS TREATED WITH DOXORUBICIN, Journal of clinical oncology, 14(2), 1996, pp. 362-372
PHARMACOLOGICAL STRATEGIES FOR THE TREATMENT OF MENINGEAL MALIGNANCY
Authors: BLANEY SM POPLACK DG
Citation: Sm. Blaney et Dg. Poplack, PHARMACOLOGICAL STRATEGIES FOR THE TREATMENT OF MENINGEAL MALIGNANCY, Investigational new drugs, 14(1), 1996, pp. 69-85
PHASE-II EVALUATION OF TOPOTECAN FOR PEDIATRIC CENTRAL-NERVOUS-SYSTEMTUMORS
Authors: BLANEY SM PHILLIPS PC PACKER RJ HEIDEMAN RL BERG SL ADAMSON PC ALLEN JC SALLAN SE JAKACKI RL LANGE BJ REAMAN GH HOROWITZ ME POPLACK DG BALIS FM
Citation: Sm. Blaney et al., PHASE-II EVALUATION OF TOPOTECAN FOR PEDIATRIC CENTRAL-NERVOUS-SYSTEMTUMORS, Cancer, 78(3), 1996, pp. 527-531
A PHASE-I AND PHASE-II TRIAL OF DOSE-INTENSIFIED CYCLOPHOSPHAMIDE ANDGM-CSF IN PEDIATRIC MALIGNANT BRAIN-TUMORS
Authors: ABRAHAMSEN TG LANGE BJ PACKER RJ VENZON DJ ALLEN JC CRAIG CE PATRONAS NJ KATZ DA GOLDWEIN JW DELANEY TF REAMAN GH PERILONGO G PHILLIPS PC OLDFIELD EH POPLACK DG HOROWITZ ME
Citation: Tg. Abrahamsen et al., A PHASE-I AND PHASE-II TRIAL OF DOSE-INTENSIFIED CYCLOPHOSPHAMIDE ANDGM-CSF IN PEDIATRIC MALIGNANT BRAIN-TUMORS, Journal of pediatric hematology/oncology, 17(2), 1995, pp. 134-139
ADVANCES IN THE TREATMENT OF MENINGEAL CANCERS
Authors: BERG SL POPLACK DG
Citation: Sl. Berg et Dg. Poplack, ADVANCES IN THE TREATMENT OF MENINGEAL CANCERS, Critical reviews in oncology/hematology, 20(1-2), 1995, pp. 87-98
CLONAL EXPANSION OF GERMLINE B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA IN SEVERE COMBINED IMMUNODEFICIENT MICE
Authors: FELIX CA WASSERMAN R CESANO A NOWELL PC HOSLER MR MASTERSON M POPLACK DG SANTOLI D
Citation: Ca. Felix et al., CLONAL EXPANSION OF GERMLINE B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA IN SEVERE COMBINED IMMUNODEFICIENT MICE, Oncogene, 11(9), 1995, pp. 1753-1759
PHARMACOKINETICS OF ALL-TRANS-RETINOIC ACID ADMINISTERED ON AN INTERMITTENT SCHEDULE
Authors: ADAMSON PC BAILEY J PLUDA J POPLACK DG BAUZA S MURPHY RF YARCHOAN R BALIS FM
Citation: Pc. Adamson et al., PHARMACOKINETICS OF ALL-TRANS-RETINOIC ACID ADMINISTERED ON AN INTERMITTENT SCHEDULE, Journal of clinical oncology, 13(5), 1995, pp. 1238-1241
EFFECT OF BODY POSITION ON VENTRICULAR CSF METHOTREXATE CONCENTRATIONFOLLOWING INTRALUMBAR ADMINISTRATION
Authors: BLANEY SM POPLACK DG GODWIN K MCCULLY CL MURPHY R BALIS FM
Citation: Sm. Blaney et al., EFFECT OF BODY POSITION ON VENTRICULAR CSF METHOTREXATE CONCENTRATIONFOLLOWING INTRALUMBAR ADMINISTRATION, Journal of clinical oncology, 13(1), 1995, pp. 177-179
INTRATHECAL ADMINISTRATION OF TOPOTECAN IN NONHUMAN-PRIMATES
Authors: BLANEY SM COLE DE GODWIN K SUNG C POPLACK DG BALIS FM
Citation: Sm. Blaney et al., INTRATHECAL ADMINISTRATION OF TOPOTECAN IN NONHUMAN-PRIMATES, Cancer chemotherapy and pharmacology, 36(2), 1995, pp. 121-124
PHARMACOKINETICS OF DIDEOXYPURINE NUCLEOSIDE ANALOGS IN PLASMA AND CEREBROSPINAL-FLUID OF RHESUS-MONKEYS
Authors: HAWKINS ME MITSUYA H MCCULLY CM GODWIN KS MURAKAMI K POPLACK DG BALIS FM
Citation: Me. Hawkins et al., PHARMACOKINETICS OF DIDEOXYPURINE NUCLEOSIDE ANALOGS IN PLASMA AND CEREBROSPINAL-FLUID OF RHESUS-MONKEYS, Antimicrobial agents and chemotherapy, 39(6), 1995, pp. 1259-1264
A PHASE-I TRIAL OF AMIFOSTINE (WR-2721) AND MELPHALAN IN CHILDREN WITH REFRACTORY CANCER
Authors: ADAMSON PC BALLS FM BELASCO JE LANGE B BERG SL BLANEY SM CRAIG C POPLACK DG
Citation: Pc. Adamson et al., A PHASE-I TRIAL OF AMIFOSTINE (WR-2721) AND MELPHALAN IN CHILDREN WITH REFRACTORY CANCER, Cancer research, 55(18), 1995, pp. 4069-4072
CHARACTERIZATION OF CROSS-RESISTANCE TO METHOTREXATE IN A HUMAN BREAST-CANCER CELL-LINE SELECTED FOR RESISTANCE TO MELPHALAN
Authors: MOSCOW JA JOHNSTON PG COLE D POPLACK DG COWAN KH
Citation: Ja. Moscow et al., CHARACTERIZATION OF CROSS-RESISTANCE TO METHOTREXATE IN A HUMAN BREAST-CANCER CELL-LINE SELECTED FOR RESISTANCE TO MELPHALAN, Biochemical pharmacology, 49(8), 1995, pp. 1069-1078
PHARMACOKINETICS OF TAXOL AND DOXORUBICIN ADMINISTERED ALONE AND IN COMBINATION BY CONTINUOUS 72-HOUR INFUSION
Authors: BERG SL COWAN KH BALIS FM FISHERMAN JS DENICOFF AM HILLIG M POPLACK DG OSHAUGHNESSY JA
Citation: Sl. Berg et al., PHARMACOKINETICS OF TAXOL AND DOXORUBICIN ADMINISTERED ALONE AND IN COMBINATION BY CONTINUOUS 72-HOUR INFUSION, Journal of the National Cancer Institute, 86(2), 1994, pp. 143-145
TOXICITY OF INTRATHECAL MELPHALAN - REPLY
Authors: BERG SL BALIS FM MCCULLY CL POPLACK DG
Citation: Sl. Berg et al., TOXICITY OF INTRATHECAL MELPHALAN - REPLY, Journal of the National Cancer Institute, 86(11), 1994, pp. 871-871
DIFFERENTIATION STAGES OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAS WITH P53 MUTATIONS
Authors: FELIX CA WASSERMAN R LANGE BJ BROWN DL NAU MM COLE DE MINNA JD POPLACK DG
Citation: Ca. Felix et al., DIFFERENTIATION STAGES OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAS WITH P53 MUTATIONS, Leukemia, 8(6), 1994, pp. 963-967
THE CYTOTOXICITY OF THIOGUANINE VS MERCAPTOPURINE IN ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: ADAMSON PC POPLACK DG BALIS FM
Citation: Pc. Adamson et al., THE CYTOTOXICITY OF THIOGUANINE VS MERCAPTOPURINE IN ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia research, 18(11), 1994, pp. 805-810
Risultati: 1-25 | 26-36